|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD
0.13 billion
|
|
CAGR
(2023-2028)
|
6.44%
|
|
Fastest
Growing Segment
|
Vascular
Stents Segment
|
|
Largest
Market
|
Abu
Dhabi
|
Market Overview
UAE
Stent Market has valued at USD 0.13 billion in 2022 and is anticipated to witness
an impressive growth in the forecast period with a CAGR of 6.44% through 2028.
A stent is a medical device used
to support or reinforce a tubular structure within the body, typically a blood
vessel or a duct. Stents are commonly employed in various medical procedures to
treat conditions that involve the narrowing or blockage of these tubular
structures. The primary purpose of a stent is to maintain the patency
(openness) of the vessel or duct, allowing for the unobstructed flow of fluids
such as blood or bile. Stents are often mesh-like, or tube-like structures made
from materials such as metal (commonly stainless steel or cobalt-chromium
alloys), polymers, or a combination of both. The design and composition can
vary based on the specific medical application. One of the most common uses of
stents is in the cardiovascular system to treat conditions like coronary artery
disease. In these cases, a vascular stent is placed to open narrowed or blocked
blood vessels. There are different types of vascular stents, including
bare-metal stents and drug-eluting stents (coated with medications to prevent
restenosis). Stents are used in the bile ducts to treat obstructions or
strictures. Biliary stents help in maintaining the flow of bile from the liver
to the small intestine and are often used in conditions such as bile duct
cancers or gallstone-related obstructions.
The
aging population in the UAE is associated with an increased risk of
cardiovascular diseases. As the population ages, there is a higher likelihood
of individuals requiring stent procedures, thereby driving market growth.
Ongoing advancements in stent
technologies, including the development of drug-eluting stents, bioresorbable
stents, and other innovative designs, can drive market growth. Healthcare
providers and patients often seek the latest and most advanced treatment
options. A rise in
healthcare expenditure, both by the government and private sectors, can
positively impact the adoption of advanced medical technologies, including
stents. Increased investment in healthcare infrastructure and services can
contribute to market growth. Growing awareness among healthcare professionals
and the general population about cardiovascular health, preventive measures,
and available treatment options can lead to earlier diagnosis and intervention,
boosting the demand for stents. Government initiatives aimed at improving
healthcare infrastructure, reducing the burden of cardiovascular diseases, and
enhancing access to advanced medical treatments can act as drivers for the
stent market.
Key Market Drivers
Technological Advancements
Drug-eluting stents are
coated with medications that are slowly released over time to prevent
restenosis (the re-narrowing of the blood vessel). This technology has
significantly reduced the incidence of restenosis compared to bare-metal
stents. Bioresorbable stents are designed to gradually dissolve over time after
they have served their purpose of keeping a blood vessel open. This technology
aims to address some limitations of permanent stents, such as the potential for
long-term complications. Fully covered stents are used in specific applications
where the entire stent is coated, providing a protective layer. These are
commonly used in the treatment of certain types of strictures in the
gastrointestinal tract. Bifurcation stents are designed for use in blood
vessels that branch into two smaller vessels. They address challenges
associated with stenting at bifurcation points and aim to improve procedural
outcomes.
The use of 3D printing
technology allows for the creation of customized stents based on the patient's
anatomy. This personalized approach can improve the fit and effectiveness of
the stent. Nanotechnology has been applied to stent coatings to enhance drug
delivery and improve the biocompatibility of the stent surface. Nano-coatings
aim to reduce inflammation and enhance the healing process. Bioactive stents
are designed to actively promote healing and tissue integration. These stents
may release substances that encourage the formation of a healthy endothelial
layer on the stent surface. Some stents are designed with dual therapy,
combining antiplatelet medications with antiproliferative drugs. This approach
aims to address both clotting and restenosis risks, providing a more
comprehensive treatment.
Advanced imaging
technologies, such as intravascular ultrasound (IVUS) and optical coherence
tomography (OCT), allow for better visualization during stent placement,
helping physicians ensure accurate positioning and optimal expansion. Emerging
technologies include stents with sensors or remote monitoring capabilities.
These stents can provide real-time information about blood flow, stent
integrity, and other relevant parameters, allowing for proactive management of
patient care. Magnetically guided stents can be navigated to specific locations
within the body using external magnetic fields. This technology enables more
precise placement and control during stent deployment. Stents with specialized
coatings that resist blood clot formation help reduce the risk of thrombosis,
enhancing the long-term safety of the device. This factor will help in the
development of the UAE
Stent Market.
Rising Awareness and Education
Improved awareness often
leads to early recognition of cardiovascular symptoms and risk factors.
Individuals who are more informed about the signs of heart disease or vascular
issues are likely to seek medical attention earlier, facilitating timely
diagnosis and intervention. Education about cardiovascular health and the
importance of preventive measures can encourage individuals to adopt a healthier
lifestyle. Lifestyle modifications, such as better dietary habits and increased
physical activity, can contribute to reducing the risk of cardiovascular
diseases, potentially lowering the need for stent interventions. Increased
education empowers patients to make informed decisions about their healthcare.
When individuals are aware of the available treatment options, including stent
procedures, they can work collaboratively with healthcare professionals to
choose the most suitable and effective interventions.
Education helps individuals
understand the role of stents in treating cardiovascular conditions. Knowing
the benefits and potential risks of stent procedures allows patients to have
realistic expectations and make informed choices based on their health status
and preferences. Improved awareness fosters better communication between
patients and healthcare providers. Informed patients are more likely to engage
in meaningful discussions with their physicians, leading to a shared
decision-making process regarding the necessity and type of intervention,
including the use of stents. In some cases, there may be a stigma or fear
associated with medical procedures. Enhanced awareness can help demystify the
stent placement process, reducing apprehension and fostering a more positive
attitude toward seeking necessary medical care.
Educational initiatives and
community outreach programs can effectively disseminate information about
cardiovascular health, risk factors, and available treatments. These programs
can target specific populations to raise awareness and promote preventive measures.
Public health campaigns focused on heart health and vascular diseases can
contribute to a broader understanding of the importance of early intervention.
These campaigns may include information about the role of stents in managing
certain cardiovascular conditions. Ongoing education for healthcare
professionals ensures that they stay informed about the latest advancements in
medical treatments, including stent technologies. Well-informed healthcare
providers are more likely to recommend appropriate interventions based on the
latest evidence and guidelines. This factor will pace up the demand of the UAE Stent Market.
Increasing Aging Population
Aging
is a significant risk factor for cardiovascular diseases such as coronary
artery disease and peripheral arterial disease. As individuals age, the
likelihood of developing atherosclerosis and other cardiovascular conditions
that may necessitate stent placement increases. Atherosclerosis, the hardening
and narrowing of arteries due to the buildup of plaque, becomes more common
with age. Stents are often used to open narrowed or blocked arteries, making
them a crucial intervention for managing atherosclerotic conditions. Elderly
individuals may present with more complex and advanced vascular lesions. Stents
are frequently employed in the treatment of complex lesions, offering a
minimally invasive solution for addressing intricate vascular issues in older
patients.
Aging
is often associated with an increased prevalence of chronic health conditions,
such as diabetes, hypertension, and hyperlipidemia. These conditions contribute
to the development and progression of cardiovascular diseases, requiring
interventions like stent placement. Older individuals, who may have multiple
comorbidities and reduced physiological reserves, often prefer minimally
invasive procedures. Stent placement procedures are typically less invasive
than traditional surgical interventions, making them suitable for older
patients. The aging population, with an increased focus on maintaining quality
of life and functionality, may seek medical interventions that can alleviate
symptoms and improve overall well-being. Stents can restore blood flow, relieve
symptoms, and enhance the quality of life for older individuals with
cardiovascular issues.
Ongoing
technological advancements in stent design and materials make them more
suitable for use in elderly patients. Innovations such as drug-eluting stents
and bioresorbable stents offer improved outcomes and address specific
challenges associated with aging vasculature. Increasing life expectancy
globally means that a growing proportion of the population is entering an age
range where cardiovascular diseases become more prevalent. This demographic
shift contributes to the overall increase in the demand for cardiovascular
interventions, including stents. As individuals age, there is a growing
emphasis on preventive healthcare. Regular screenings and early detection of
cardiovascular risk factors may lead to interventions like stent placement at
earlier stages, preventing the progression of vascular diseases. This factor will
accelerate the demand of the UAE Stent Market.
Download Sample Report
Key Market Challenges
Market
Saturation
As the market becomes saturated, the
number of competitors increases. This intensifies competition among stent
manufacturers and distributors, putting pressure on prices and profit margins. With
a high level of competition, manufacturers may engage in price wars to gain
market share. This can lead to price erosion, impacting on the overall revenue
and profitability of companies operating in the stent market. In a saturated
market, products may become commoditized, and differentiation between various
stent offerings may diminish. This makes it challenging for manufacturers to
stand out based on unique features or benefits. Saturated markets may
experience slower growth rates compared to emerging markets. The demand for
stents may become more stable, and expansion opportunities may be limited,
impacting the overall growth potential of companies. Companies may find it
challenging to increase their market share significantly in a saturated market.
Growth strategies become more complex, and gaining a larger share of the market
becomes increasingly difficult. To overcome market saturation, companies need
to continually innovate and introduce new products or improvements to existing
products. However, innovation in the medical device sector, including stents,
often requires significant research and development investments.
Patient Safety Concerns
Patient
safety concerns may arise due to complications associated with stent thrombosis
(blood clot formation) and restenosis (re-narrowing of the treated blood
vessel). Addressing these issues is crucial to prevent adverse events and
ensure the long-term success of stent interventions. Any invasive medical
procedure, including stent placement, carries a risk of infection. Ensuring
aseptic techniques during procedures and promoting proper postoperative care
are essential to minimize infection risk and enhance patient safety. Some
patients may be allergic to the materials used in stent coatings or components.
Ensuring thorough patient assessment, including a history of allergies, and
using biocompatible materials are important measures to mitigate the risk of
allergic reactions. Anticoagulant and antiplatelet medications are often
prescribed after stent placement to prevent blood clots. However, the use of
these medications carries a risk of bleeding complications. Balancing the need
for anticoagulation with the risk of bleeding is a delicate consideration in
patient safety. Issues related to vascular access, such as bleeding, hematoma
formation, or pseudoaneurysm, can occur during or after stent procedures.
Proper vascular access management is crucial for minimizing complications and
ensuring patient safety.
Key Market Trends
Focus on Outpatient Care
Stent placement procedures are often minimally
invasive, making them suitable for outpatient settings. Advances in technology
and techniques have allowed for shorter procedure times and quicker recovery,
facilitating the transition to outpatient care. Outpatient care generally
incurs lower costs compared to inpatient care. Patients undergoing stent
procedures in outpatient settings may experience cost savings associated with
shorter hospital stays and reduced resource utilization. Technological
advancements, including the development of drug-eluting stents and improved
procedural techniques, contribute to shorter recovery times. This supports the
feasibility of performing stent procedures on an outpatient basis. The
implementation of enhanced recovery after surgery (ERAS) protocols promotes
faster patient recovery. These protocols, which include optimized pain
management and early mobilization, align with the goals of outpatient care. Many
patients prefer receiving care in familiar and comfortable environments, and
outpatient settings often provide a more relaxed atmosphere compared to
inpatient facilities. Offering stent procedures on an outpatient basis can
align with patient preferences. Outpatient care allows for the efficient use of
healthcare resources, optimizing the utilization of outpatient facilities and
freeing up inpatient beds for more complex cases. This can contribute to
overall healthcare system efficiency.
Segmental Insights
Product Type Insights
In 2022, the UAE Stent Market largest share was held by Vascular
Stent segment and is predicted to continue expanding over the coming years. Vascular stents are commonly used in the
treatment of cardiovascular diseases, such as coronary artery disease. Given
the high prevalence of cardiovascular conditions in the population, the demand
for vascular stents is likely to be substantial. Vascular stents, particularly
coronary stents, are widely used in interventional cardiology procedures such
as percutaneous coronary intervention (PCI) to treat narrowed or blocked coronary
arteries. The significant burden of coronary artery disease contributes to the
prominence of vascular stents in the market. Ongoing advancements in vascular
stent technologies, including drug-eluting stents and bioresorbable stents,
enhance their efficacy in treating vascular conditions. The adoption of
innovative and advanced products may contribute to the dominance of the Vascular
Stent segment. Vascular stents are often deployed in minimally invasive
procedures, such as angioplasty and stent placement, which offer benefits such
as quicker recovery times and reduced hospital stays. The preference for
minimally invasive interventions could drive the demand for vascular stents. Vascular
stents are utilized in the treatment of peripheral arterial disease (PAD), a
condition affecting blood vessels outside the heart and brain. The prevalence
of PAD, especially in the aging population, contributes to the demand for
vascular stents.
Type Insights
In 2022, the UAE Stent Market largest share was held by Self-Expandable
segment and is predicted to continue expanding over the coming years. Self-expandable stents have a flexible design that allows them to
adapt to the natural contours of blood vessels. This characteristic makes them
suitable for a variety of anatomical structures, including vessels with complex
shapes or lesions. Self-expandable stents are often used in minimally invasive
procedures, such as percutaneous transluminal angioplasty (PTA) and
endovascular interventions. These procedures involve less trauma to the
patient, shorter recovery times, and reduced hospital stays compared to
traditional surgical interventions. The deployment process for self-expandable
stents is generally straightforward. The stent is compressed for delivery and
then expands to the desired diameter once in position. This ease of deployment
can contribute to procedural efficiency and reduce the time required for the
intervention. Self-expandable stents are well-suited for the treatment of
complex vascular lesions, including those with varying diameters or locations.
Their ability to conform to different vessel sizes makes them effective in
addressing a range of clinical scenarios. Self-expandable stents often have a
secure anchoring mechanism that reduces the risk of stent migration or
dislodgement after placement. This can enhance the long-term effectiveness of
the stent in maintaining vessel patency.
End-User Insights
In 2022, the UAE Stent Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue
expanding over the coming years. Hospitals
and clinics typically have well-established medical infrastructure, including
specialized cardiovascular departments and catheterization laboratories
equipped for interventional procedures like stent placements. This
infrastructure enables the efficient diagnosis and treatment of cardiovascular
conditions, leading to a higher demand for stents. Hospitals and clinics often
employ specialized healthcare professionals, including cardiologists,
interventional radiologists, and cardiovascular surgeons. These professionals
are trained to perform stent procedures and manage cardiovascular diseases, contributing
to a higher volume of stent-related interventions in these settings. Hospitals
and clinics are often referral centres for patients with complex medical
conditions. Physicians in smaller healthcare facilities may refer patients to
larger hospitals or clinics for specialized treatments, including stent
procedures. This referral network can concentrate stent procedures in hospital
settings. Hospitals are equipped to handle emergency cases and critical medical
conditions, including acute cardiovascular events that may require immediate
stent placement. The urgency and complexity of such cases often lead to a
significant number of stent procedures being performed in hospital settings.
Download Sample Report
Regional Insights
The Abu Dhabi region
dominates the UAE Stent Market in 2022. Abu
Dhabi, being the capital of the UAE, often has well-developed healthcare
infrastructure, including advanced hospitals, medical facilities, and
specialized healthcare services. A robust healthcare system can contribute to a
higher demand for medical devices such as stents. The economic strength of the
Abu Dhabi region may influence healthcare spending and investment in medical
technologies. Regions with higher economic resources often have better access
to advanced medical treatments and devices. Abu Dhabi is a hub for medical
tourism, it could attract patients from other regions and countries seeking
advanced medical treatments, including stent procedures. This influx of
patients could contribute to a higher demand for medical devices. Abu Dhabi
hosts research and development centers, medical institutions, or universities
specializing in cardiovascular health. It may lead to innovation and
advancements in stent technologies, driving the market in that region.
Recent Developments
- In February 2019, Med Surg
Solutions, an authorized distributor of Gore, proudly sponsored the PAIRS
International Congress held in Dubai from February 27th to March 2nd, 2019. At
the congress, MSS introduced its Conformable GORE® TAG® Thoracic Endoprosthesis
Stent Graft featuring the new ACTIVE CONTROL delivery system. This system
ensures precise control and predictable stent placement for TEVAR. The MSS
booth hosted Gore Medical Mastery Series hands-on simulations, offering interactive
sessions for doctors to gain a comprehensive understanding of device design.
Key Market Players
- Medtronic Meta FZ-LLC
- Boston Scientific Corporation UAE
- Becton Dickinson, and Company
- CONMED Corporation UAE
- Stryker ESCS BV
- Abbott Laboratories S. A
- B. Braun Medical Inc.
|
By
Product Type
|
By Material
Type
|
By
Type
|
By
End-User
|
By Region
|
- Vascular
Stent
- Non-Vascular
Stents
|
|
- Balloon
Expandable
- Self-Expandable
|
- Hospitals
& Clinics
- Ambulatory
Care Centers
- Others
|
- Dubai
- Abu
Dhabi
- Sharjah
- Rest
of UAE
|
Report Scope:
In this report, the
UAE Stent Market has been segmented
into the following categories, in addition to the industry trends which have
also been detailed below:
- Stent Market, By Product Type:
o Vascular Stent
o Non-Vascular Stents
- Stent Market, By Material Type:
o Metal
o Polymer
o Balloon Expandable
o Self-Expandable
- Stent
Market, By End-User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Others
o
Dubai
o
Abu
Dhabi
o
Sharjah
o
Rest
of UAE
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies presents in the UAE Stent Market.
Available Customizations:
UAE Stent Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
UAE Stent Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]